Dextromethorphan Added on for the Patients With ADHD

• Status: Available
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Dextromethorphan added on methylphenidate for the patients with attention deficit hyperactivity disorder

Details

• Lead Sponsor: Tri-Service General Hospital
• Treatments: Dextromethorphan

Criteria

Inclusion Criteria:

• Patients aged 6 to 25 who have ADHD symptoms will be recruited. They will be screened for the ADHD symptoms with SNAP 4th version. They then will be referred to a psychiatrist to make a final diagnosis of ADHD by the American Diagnostic Statistical Manual 4th version (DSM-IV).

Exclusion Criteria:

• Patients not willing to participate in the study after detailed explanation.

• Patients who could not follow the investigator's instructions

• Patients who have severe neurological or mental illness like epileptic disorder, history of stroke, schizophrenia, bipolar disorder, mental retardation or uncontrolled suicide risk.

• Patients who have severe medical illness or surgical conditions like uncontrolled abnormal thyroid function, history of heart attack, uncontrolled hypertension.

• Patients who are taking antidepressants, psychotropic medicines within two months prior to the evaluation for entering our study.

• Patients who are allergic to methylphenidate or dextromethorphan.

• Patients with autoimmune disorders

• Patients with asthma or severe infection disorder currently or in the previous two months to avoid the influence of the level of cytokines.